Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial-Reference-Cited by-同舟云学术

Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial

Published:2024-08 Issue: Volume:126 Page:89-94
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Landi Antonio^ORCID,Heg Dik,Frigoli Enrico^ORCID,Tonino Pim A.L.,Vranckx Pascal,Pourbaix Suzanne^ORCID,Chevalier Bernard,Iñiguez Andrés,Pinar Eduardo,Lesiak Maciej,Kala Petr,Donahue Michael,Windecker Stephan,Roffi Marco,Smits Pieter C.,Valgimigli Marco

Publisher

Elsevier BV

Reference26 articles.

1. Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk;Corpataux;Eur Heart J,2020

2. Validation of the Academic Research Consortium High Bleeding Risk definition in contemporary PCI patients;Cao;J Am Coll Cardiol,2020

3. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores;Ueki;EuroIntervention,2020

4. Antithrombotic therapy in patients with established atherosclerotic coronary disease;Landi;Heart,2023

5. Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease;Valgimigli;Eur Heart J Cardiovasc Pharmacother,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution;European Heart Journal;2024-08-28